For those seeking culinary experiences beyond seafood, the Casino Bar & Grill in nearby Bodega (remember, that’s the inland village) serves hearty comfort food in a historic setting that feels like ...

A new in vivo approach to chimeric antigen receptor T-cell (CAR-T) therapy could extend the technology’s use beyond cancer, as a treatment for autoimmune disease (Science 2025, DOI: 10.1126 ...

Label updates have been approved by the FDA for the CAR T-cell therapies Breyanzi and Abecma in large B cell lymphoma and multiple myeloma, respectively.

CAR-T is a powerful tool which is still evolving. Chaitanya Erady highlights what's new in CAR-T cell therapy.

Dr. Andre Henri Goy shared how CAR T-cell therapy led a retired pilot with lymphoma into remission, showing the impact of personalized treatment decisions.

According to a EULAR press release, the data “suggest the potential for CAR T-cell therapy and other B-cell depleting therapies to reset the immune system in multiple RMD, allowing patients to ...

A team of researchers from the San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET, Milan), led by Nadia Coltella and Luigi Naldini, has unveiled a powerful strategy to rejuvenate the ...

Mansi Shah, MD, explains how treatment sequencing and patient eligibility guide the use of these therapies in multiple myeloma.

The U.S. Food and Drug Administration said on Friday it had eliminated risk evaluation and mitigation strategies (REMS), a safety program to protect patients from risky drugs, for currently ...

The seventh FDA-approved CAR T-therapy is Aucatzyl, an Autolus Therapeutics cell therapy engineered with properties intended to improve safety.